Alaunos Therapeutics Inc. (TCRT)
$1.56
$-0.01
(-0.64%)
As on 09-Sep-2026 14:37EDT
Market cap
$4 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
6.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.9 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-3.5
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.9
-
Face value
--
-
Shares outstanding
2,540,480
10 Years Aggregate
CFO
$-417.82 Mln
EBITDA
$-659.71 Mln
Net Profit
$-831.00 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Alaunos Therapeutics (TCRT)
| -51.7 | -21.6 | -22.0 | -28.8 | -56.6 | -64.8 | -46.4 |
|
BSE Sensex
| -11.7 | -4.8 | 1.7 | -7.5 | 3.9 | 5.1 | 9.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Alaunos Therapeutics (TCRT)
| 69.6 | -81.6 | -89.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Alaunos Therapeutics (TCRT)
|
1.6 | 4.1 | 0.0 | -4.0 | -133,666.7 | -285.9 | -- | 6.4 |
| 83.2 | 12,161.6 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.2 | |
| 263.1 | 17,746.8 | 1,054.4 | 755.9 | 5.7 | -- | 20.9 | 10.5 | |
| 74.2 | 10,109.8 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.5 | |
| 58.0 | 14,621.6 | 2,435.9 | 860.6 | 31.0 | 43 | 18.6 | 7.9 | |
| 107.3 | 12,506.3 | 1,663.7 | 413.6 | 36.3 | 430 | 32.3 | 86.7 | |
| 345.5 | 10,603.5 | 440.5 | 241.5 | 33.4 | 18.7 | 44.9 | 8.1 | |
| 115.6 | 9,761.1 | 105.0 | -299.7 | -227.2 | -19.4 | -- | 6.5 | |
| 543.1 | 12,501.2 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 23.9 | |
| 582.8 | 16,503.9 | 2,782.3 | 491.5 | 21.1 | 110.1 | 34.7 | 38.2 |
Shareholding Pattern
View DetailsAbout Alaunos Therapeutics (TCRT)
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach,... and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida. Read more
-
Interim CEO & Director
Mr. Dale Curtis Hogue Jr.
-
Interim CEO & Director
Mr. Dale Curtis Hogue Jr.
-
Headquarters
Fort Lauderdale, FL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Alaunos Therapeutics (TCRT)
What is the current share price of Alaunos Therapeutics Inc (TCRT) Today?
The share price of Alaunos Therapeutics Inc (TCRT) is $1.56 (NASDAQ) as of 09-Sep-2026 14:37 EDT. Alaunos Therapeutics Inc (TCRT) has given a return of -56.62% in the last 3 years.
What is the current PB & PE ratio of Alaunos Therapeutics Inc (TCRT)?
Since, TTM earnings of Alaunos Therapeutics Inc (TCRT) is negative, P/E ratio is not available.
The P/B ratio of Alaunos Therapeutics Inc (TCRT) is 6.43 times as on 04-Sep-2026, a 21 premium to its peers’ median range of 5.33 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-1.51 |
2.92 |
2024 |
-0.65 |
1.48 |
2023 |
0.00 |
0.02 |
2022 |
-0.03 |
0.03 |
2021 |
-0.02 |
0.03 |
What is the 52 Week High and Low of Alaunos Therapeutics Inc (TCRT)?
The 52-week high and low of Alaunos Therapeutics Inc (TCRT) are Rs 4.59 and Rs 1.55 as of 10-Sep-2026.
What is the market cap of Alaunos Therapeutics Inc (TCRT)?
Alaunos Therapeutics Inc (TCRT) has a market capitalisation of $ 4 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Alaunos Therapeutics Inc (TCRT)?
Before investing in Alaunos Therapeutics Inc (TCRT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.